Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica

OBJECTIVE: To 1) determine, using contemporary recombinant antigen–based assays, the aquaporin-4 (AQP4)–immunoglobulin G (IgG) detection rate in sequential sera of patients assigned a clinical diagnosis of neuromyelitis optica (NMO) but initially scored negative by tissue-based indirect immunofluore...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jiao, Yujuan, Fryer, James P., Lennon, Vanda A., Jenkins, Sarah M., Quek, Amy M.L., Smith, Carin Y., McKeon, Andrew, Costanzi, Chiara, Iorio, Raffaele, Weinshenker, Brian G., Wingerchuk, Dean M., Shuster, Elizabeth A., Lucchinetti, Claudia F., Pittock, Sean J.
Formato: Artigo
Lenguaje:Inglês
Publicado: Lippincott Williams & Wilkins 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3795610/
https://ncbi.nlm.nih.gov/pubmed/23997151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182a6cb5c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares